174 related articles for article (PubMed ID: 25866181)
1. In vivo characterization of human myofibrillar myopathy genes in zebrafish.
Bührdel JB; Hirth S; Kessler M; Westphal S; Forster M; Manta L; Wiche G; Schoser B; Schessl J; Schröder R; Clemen CS; Eichinger L; Fürst DO; van der Ven PF; Rottbauer W; Just S
Biochem Biophys Res Commun; 2015 May; 461(2):217-23. PubMed ID: 25866181
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency.
Ruparelia AA; Oorschot V; Vaz R; Ramm G; Bryson-Richardson RJ
Acta Neuropathol; 2014 Dec; 128(6):821-33. PubMed ID: 25273835
[TBL] [Abstract][Full Text] [Related]
3. Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency.
Diofano F; Weinmann K; Schneider I; Thiessen KD; Rottbauer W; Just S
PLoS Genet; 2020 Nov; 16(11):e1009088. PubMed ID: 33137814
[TBL] [Abstract][Full Text] [Related]
4. Human Mutated
Cannone E; Guglielmi V; Marchetto G; Tobia C; Gnutti B; Cisterna B; Tonin P; Barbon A; Vattemi G; Schiavone M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511242
[TBL] [Abstract][Full Text] [Related]
5. Candidate gene expression and coding sequence variants in Warmblood horses with myofibrillar myopathy.
Williams ZJ; Velez-Irizarry D; Petersen JL; Ochala J; Finno CJ; Valberg SJ
Equine Vet J; 2021 Mar; 53(2):306-315. PubMed ID: 32453872
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histopathological features of myofibrillar myopathy in Warmblood horses.
Valberg SJ; Nicholson AM; Lewis SS; Reardon RA; Finno CJ
Equine Vet J; 2017 Nov; 49(6):739-745. PubMed ID: 28543538
[TBL] [Abstract][Full Text] [Related]
7. Myofibrillar myopathies: new developments.
Olivé M; Kley RA; Goldfarb LG
Curr Opin Neurol; 2013 Oct; 26(5):527-35. PubMed ID: 23995273
[TBL] [Abstract][Full Text] [Related]
8. New aspects of myofibrillar myopathies.
Kley RA; Olivé M; Schröder R
Curr Opin Neurol; 2016 Oct; 29(5):628-34. PubMed ID: 27389816
[TBL] [Abstract][Full Text] [Related]
9. BAG3
Robertson R; Conte TC; Dicaire MJ; Rymar VV; Sadikot AF; Bryson-Richardson RJ; Lavoie JN; O'Ferrall E; Young JC; Brais B
Am J Pathol; 2020 Mar; 190(3):554-562. PubMed ID: 31953038
[TBL] [Abstract][Full Text] [Related]
10. Novel recessive myotilin mutation causes severe myofibrillar myopathy.
Schessl J; Bach E; Rost S; Feldkirchner S; Kubny C; Müller S; Hanisch FG; Kress W; Schoser B
Neurogenetics; 2014 Aug; 15(3):151-6. PubMed ID: 24928145
[TBL] [Abstract][Full Text] [Related]
11. Characterization and investigation of zebrafish models of filamin-related myofibrillar myopathy.
Ruparelia AA; Zhao M; Currie PD; Bryson-Richardson RJ
Hum Mol Genet; 2012 Sep; 21(18):4073-83. PubMed ID: 22706277
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in myofibrillar myopathy.
Vincent AE; Grady JP; Rocha MC; Alston CL; Rygiel KA; Barresi R; Taylor RW; Turnbull DM
Neuromuscul Disord; 2016 Oct; 26(10):691-701. PubMed ID: 27618136
[TBL] [Abstract][Full Text] [Related]
13. Myofibrillar myopathy in the genomic context.
Fichna JP; Maruszak A; Żekanowski C
J Appl Genet; 2018 Nov; 59(4):431-439. PubMed ID: 30203143
[TBL] [Abstract][Full Text] [Related]
14. Myofibrillar myopathies: State of the art, present and future challenges.
Béhin A; Salort-Campana E; Wahbi K; Richard P; Carlier RY; Carlier P; Laforêt P; Stojkovic T; Maisonobe T; Verschueren A; Franques J; Attarian S; Maues de Paula A; Figarella-Branger D; Bécane HM; Nelson I; Duboc D; Bonne G; Vicart P; Udd B; Romero N; Pouget J; Eymard B
Rev Neurol (Paris); 2015 Oct; 171(10):715-29. PubMed ID: 26342832
[TBL] [Abstract][Full Text] [Related]
15. Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.
Semmler AL; Sacconi S; Bach JE; Liebe C; Bürmann J; Kley RA; Ferbert A; Anderheiden R; Van den Bergh P; Martin JJ; De Jonghe P; Neuen-Jacob E; Müller O; Deschauer M; Bergmann M; Schröder JM; Vorgerd M; Schulz JB; Weis J; Kress W; Claeys KG
Orphanet J Rare Dis; 2014 Aug; 9():121. PubMed ID: 25208129
[TBL] [Abstract][Full Text] [Related]
16. A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.
Keßler M; Kieltsch A; Kayvanpour E; Katus HA; Schoser B; Schessl J; Just S; Rottbauer W
Neuromuscul Disord; 2018 Jun; 28(6):521-531. PubMed ID: 29735270
[TBL] [Abstract][Full Text] [Related]
17. Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches.
Batonnet-Pichon S; Behin A; Cabet E; Delort F; Vicart P; Lilienbaum A
J Neuromuscul Dis; 2017; 4(1):1-15. PubMed ID: 28269794
[TBL] [Abstract][Full Text] [Related]
18. Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization.
O'Grady GL; Best HA; Sztal TE; Schartner V; Sanjuan-Vazquez M; Donkervoort S; Abath Neto O; Sutton RB; Ilkovski B; Romero NB; Stojkovic T; Dastgir J; Waddell LB; Boland A; Hu Y; Williams C; Ruparelia AA; Maisonobe T; Peduto AJ; Reddel SW; Lek M; Tukiainen T; Cummings BB; Joshi H; Nectoux J; Brammah S; Deleuze JF; Ing VO; Ramm G; Ardicli D; Nowak KJ; Talim B; Topaloglu H; Laing NG; North KN; MacArthur DG; Friant S; Clarke NF; Bryson-Richardson RJ; Bönnemann CG; Laporte J; Cooper ST
Am J Hum Genet; 2016 Nov; 99(5):1086-1105. PubMed ID: 27745833
[TBL] [Abstract][Full Text] [Related]
19. Proteome and transcriptome profiling of equine myofibrillar myopathy identifies diminished peroxiredoxin 6 and altered cysteine metabolic pathways.
Valberg SJ; Perumbakkam S; McKenzie EC; Finno CJ
Physiol Genomics; 2018 Dec; 50(12):1036-1050. PubMed ID: 30289745
[TBL] [Abstract][Full Text] [Related]
20. FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency.
Ruparelia AA; Oorschot V; Ramm G; Bryson-Richardson RJ
Hum Mol Genet; 2016 Jun; 25(11):2131-2142. PubMed ID: 26969713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
